Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Debt to Equity: 2009-2024

Historic Debt to Equity for Prestige Consumer Healthcare (PBH) over the last 11 years, with Mar 2024 value amounting to $0.68.

  • Prestige Consumer Healthcare's Debt to Equity fell 26.86% to $0.68 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.68, marking a year-over-year decrease of 26.86%. This contributed to the annual value of $0.68 for FY2024, which is 26.86% down from last year.
  • According to the latest figures from Q1 2024, Prestige Consumer Healthcare's Debt to Equity is $0.68, which was down 26.86% from $0.93 recorded in Q1 2023.
  • In the past 5 years, Prestige Consumer Healthcare's Debt to Equity registered a high of $1.48 during Q1 2020, and its lowest value of $0.00 during Q3 2021.
  • Moreover, its 3-year median value for Debt to Equity was $0.93 (2023), whereas its average is $0.85.
  • Data for Prestige Consumer Healthcare's Debt to Equity shows a maximum YoY crashed of 99.66% (in 2021) over the last 5 years.
  • Prestige Consumer Healthcare's Debt to Equity (Quarterly) stood at $1.17 in 2020, then slumped by 99.66% to $0.00 in 2021, then declined by 14.08% to $0.94 in 2022, then decreased by 0.64% to $0.93 in 2023, then dropped by 26.86% to $0.68 in 2024.
  • Its last three reported values are $0.68 in Q1 2024, $0.93 for Q1 2023, and $0.94 during Q1 2022.